Documentos relacionados

1. Neurological symptoms and signs in HTLV-1 patients with overactive bladder syndrome.
2. The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy.
3. Pentraxin 3, a serum biomarker in human T-cell lymphotropic virus type-1-associated myelopathy patients and asymptomatic carriers.
4. Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection.
5. HTLV, a multi organ oncovirus.
6. The use of botulinum toxin type A in the treatment of HTLV-1-associated overactive bladder refractory to conventional therapy
7. Retrospective clinic and urodynamic study in the neurogenic bladder dysfunction caused by human T cell lymphotrophic virus type 1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
8. Patient research priority setting partnership in human T-cell lymphotropic virus type I.
9. Spasticity distribution and severity in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis.
10. Particularities of Neurological Manifestations in Adult T-Cell Leukemia/Lymphoma: Need for a Multidisciplinary Approach-A Narrative Review.